O relatório
Análises profundas sobre financiamento de empresas, estratégias de crescimento e insights de mercado dos negócios mais inovadores do mundo
197 relatórios e mais
Grin Therapeutics Raises $140M in Series D
Grin Therapeutics, a Biotech company based in New York, NY, has raised $140M in Series D at a $700M valuation led by Fidelity, Viking Global.
Grin Therapeutics raises $140M Series D at $700M valuation
Grin Therapeutics raises $140M in Series D at $700M valuation. Developer of therapies treating serious neurodevelopmental disorders...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Expedition Therapeutics raises $165M Series B at $850M valuation
Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...
Kailera Therapeutics raises $400M Series A at $1.5B valuation
Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...
Mostrando 9 relatórios • Página 1 • Categoria: all
Fique à frente do mercado
Receba insights semanais em sua caixa de entrada. Sem spam, apenas inteligência.